Cited by 266Autophagy in Disease and TherapyGenetic Neurodegenerative DiseasesAlzheimer's disease research and treatments

A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model

Open access
Tsvetkov, Andrey S., Miller, Jason, Arrasate, Montserrat, Wong, Jinny S., Pleiss, Michael A., Finkbeiner, Steven·2010·Proceedings of the National Academy of Sciences

Abstract

Autophagy is an intracellular turnover pathway. It has special relevance for neurodegenerative proteinopathies, such as Alzheimer disease, Parkinson disease, and Huntington disease (HD), which are characterized by the accumulation of misfolded proteins. Although induction of autophagy enhances clearance of misfolded protein and has therefore been suggested as a therapy for proteinopathies, neurons appear to be less responsive to classic autophagy inducers than nonneuronal cells. Searching for improved inducers of neuronal autophagy, we discovered an N 10 -substituted phenoxazine that, at proper doses, potently and safely up-regulated autophagy in neurons in an Akt- and mTOR-independent fashion. In a neuron model of HD, this compound was neuroprotective and decreased the accumulation of diffuse and aggregated misfolded protein. A structure/activity analysis with structurally similar compounds approved by the US Food and Drug Administration revealed a defined pharmacophore for inducing neuronal autophagy. This pharmacophore should prove useful in studying autophagy in neurons and in developing therapies for neurodegenerative proteinopathies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1004498107

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Selective MTORC1 inhibition via everolimus or modulation of MTOR- and AKT-independent pathways with 10-NCP are more successful in neurons.

    “Alternative methods have proven more successful in neurons, however, including selective MTORC1 inhibition via everolimus [385–387], or modulation of MTOR- and AKT-independent pathways with 10-NCP, an N10-substituted derivative of the heterocyclic dye compound and antipsychotic analog phenoxazine [384].”
  • Rapamycin and related MTOR inhibitors, as well as AKT inhibitors, are ineffective inducers of neuronal autophagy.

    “rapamycin and related MTOR inhibitors, as well as AKT inhibitors, are ineffective inducers of neuronal autophagy [338,384].”
  • 10-NCP and related compounds are capable of inducing neuronal autophagy through an MTOR- and AKT-independent signaling cascade.

    “10-NCP and related compounds are also capable of inducing neuronal autophagy through an MTOR- and AKT-independent signaling cascade [357,384].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tsvetkov, A. S., Miller, J., Arrasate, M., Wong, J. S., Pleiss, M. A., & Finkbeiner, S.
Affiliations
University of California, San Francisco (US)
Venue
Proceedings of the National Academy of Sciences
Published
2010-09-10
Volume
107
Issue
39
Pages
16982-16987
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2045647507
Cited by
266
References
33
Citations by year
2026: 9 · 2025: 8 · 2024: 7 · 2023: 5 · 2022: 12 · 2021: 23 · 2020: 21 · 2019: 19 · 2018: 20 · 2017: 24 · 2016: 20 · 2015: 17 · 2014: 22 · 2013: 25 · 2012: 19
FWCI
13.77
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Hereditary Disease Foundation
  • Gladstone Institutes
  • Tokyo Medical and Dental University
  • National Institutes of Health (1c06rr018928-01, AG‐022074, NS045191)
  • University of California, San Diego
  • University of California, San Francisco
  • National Institute on Aging (P01AG022074)
  • National Institute of General Medical Sciences
  • National Institute of Neurological Disorders and Stroke (R01NS039746, R01NS045191)
  • National Center for Research Resources (C06-RR-018928)
Topics
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
autophagy, Huntington's disease, neuronal autophagy, phenoxazine, neuroprotection, protein aggregation, neurodegenerative proteinopathies, structure-activity relationship, pharmacophore, mTOR-independent autophagy
MeSH terms
Animals, Autophagy, Cells, Cultured, Huntington Disease, Neurons, Oxazines, Drug Approval, Protein Serine-Threonine Kinases, Protein Folding, Neuroprotective Agents, Cytoprotection, Intracellular Signaling Peptides and Proteins, Proto-Oncogene Proteins c-akt, Mice, Rats, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review